420 with CNW - New Study Finds Delta-8 THC is Highly Used in Prohibitionist States

420 with CNW - New Study Finds Delta-8 THC is Highly Used in Prohibitionist States

2025-09-08 16:25:00 ET

A new study has revealed that Delta-8 THC , a psychoactive component often marketed as a legal substitute for cannabis, is most frequently used in states where cannabis is illegal and delta-8 products are not regulated.

Creating legal markets where entities like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) operate can help in protecting public health by…

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

News Provided by CannabisNewsWire via QuoteMedia

CRON:US
The Conversation (0)
Cronos Group Inc.

Cronos Group Inc.

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Latest Press Releases

Related News

×